scispace - formally typeset
A

Alain M. Gardier

Researcher at Université Paris-Saclay

Publications -  154
Citations -  9679

Alain M. Gardier is an academic researcher from Université Paris-Saclay. The author has contributed to research in topics: Serotonin & Antidepressant. The author has an hindex of 51, co-authored 149 publications receiving 8731 citations. Previous affiliations of Alain M. Gardier include Centre national de la recherche scientifique & French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Neurogenesis-Dependent and -Independent Effects of Fluoxetine in an Animal Model of Anxiety/Depression

TL;DR: A mouse model of an anxiety/depressive-like state induced by chronic corticosterone treatment is described, and mice deficient in one of these genes, beta-arrestin 2, displayed a reduced response to fluoxetine in multiple tasks, suggesting that beta-Arrestin signaling is necessary for the antidepressant effects of fluoxettine.
Journal ArticleDOI

Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors.

TL;DR: The efficient re-expression of electrophysiologically responsive, ligand-binding nicotinic acetylcholine receptors in dopamine-containing neurons of the VTA is demonstrated, together with the recovery of nicotine-elicited dopamine release and nicotine self-administration.
Journal ArticleDOI

Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression.

TL;DR: Investigating putative mechanisms shows that this core MDD-related gene profile is recapitulated by complementary patterns in mice with constitutive or activity-dependent decreases in BDNF function, particularly affecting SST/NPY-related GABA neurons, thus linking the neurotrophic and GABA hypotheses of depression.